Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

TRAV1-2+ CD8+ T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis.

Wong EB, Gold MC, Meermeier EW, Xulu BZ, Khuzwayo S, Sullivan ZA, Mahyari E, Rogers Z, Kløverpris H, Sharma PK, Worley AH, Lalloo U, Baijnath P, Ambaram A, Naidoo L, Suleman M, Madansein R, McLaren JE, Ladell K, Miners KL, Price DA, Behar SM, Nielsen M, Kasprowicz VO, Leslie A, Bishai WR, Ndung'u T, Lewinsohn DM.

Commun Biol. 2019 Jun 5;2:203. doi: 10.1038/s42003-019-0442-2. eCollection 2019.

2.

Diagnostic Challenge of Tuberculosis Heterogeneity.

Nemes E, Meermeier EW, Scriba TJ, Walzl G, Malherbe ST, Lewinsohn DM.

Semin Respir Crit Care Med. 2018 Jun;39(3):286-296. doi: 10.1055/s-0038-1660471. Epub 2018 Aug 2. Review.

PMID:
30071544
3.

MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage.

Harriff MJ, McMurtrey C, Froyd CA, Jin H, Cansler M, Null M, Worley A, Meermeier EW, Swarbrick G, Nilsen A, Lewinsohn DA, Hildebrand W, Adams EJ, Lewinsohn DM.

Sci Immunol. 2018 Jul 13;3(25). pii: eaao2556. doi: 10.1126/sciimmunol.aao2556.

PMID:
30006464
4.

Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis?

Meermeier EW, Lewinsohn DM.

F1000Res. 2018 May 25;7. pii: F1000 Faculty Rev-664. doi: 10.12688/f1000research.13224.1. eCollection 2018. Review.

5.

MAIT cells and microbial immunity.

Meermeier EW, Harriff MJ, Karamooz E, Lewinsohn DM.

Immunol Cell Biol. 2018 Jul;96(6):607-617. doi: 10.1111/imcb.12022. Epub 2018 Mar 9. Review.

6.

Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.

Meermeier EW, Laugel BF, Sewell AK, Corbett AJ, Rossjohn J, McCluskey J, Harriff MJ, Franks T, Gold MC, Lewinsohn DM.

Nat Commun. 2016 Aug 16;7:12506. doi: 10.1038/ncomms12506.

7.

Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.

Laugel B, Lloyd A, Meermeier EW, Crowther MD, Connor TR, Dolton G, Miles JJ, Burrows SR, Gold MC, Lewinsohn DM, Sewell AK.

J Immunol. 2016 Aug 1;197(3):971-82. doi: 10.4049/jimmunol.1501402. Epub 2016 Jun 15.

Supplemental Content

Loading ...
Support Center